Back to Bank of America Corp. Bank of America Corp.

MRKR

Showing 7 of 13 quarters

Position history for Bank of America Corp.Bank of America Corp.'s holdings in Marker Therapeutics, Inc.

No. Bank of America exited its MRKR (Marker Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 1,126 shares worth $1,678. Bank of America first reported MRKR in Q1 2023 and held it in 12 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$7,380

Total Shares Change

-2,617

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$1.30
0
2025-Q4
Increased
1,126
+0.3%
$1,6780.0%$1.49
8
2025-Q3
Increased
1,123
+0.8%
$1,0010.0%$0.89
8
2025-Q2
Decreased
1,114
-65.5%
$1,7040.0%$1.53
0
2025-Q1
Increased
3,231
+0.4%
$3,9740.0%$1.23
10
2024-Q4
Increased
3,218
+23.0%
$10,0080.0%$3.11
14
2024-Q3
Increased
2,617
+0.0%
$7,3800.0%$2.82
11

Other major holders of MRKR: Alyeska Investment Group, L.P., Hudson Bay Capital Management LP, Vanguard Group Inc., Vanguard Capital Management LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used